Glimison-M 2 Tablet PR
By Glimison-M
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg)

Manufacturer - Unison Pharmaceuticals Pvt Ltd
Unison Pharmaceuticals Pvt. Ltd., UNISON HOUSE Near Prernatirth Derasar, Near Ratnadeep-II, Satellite, Jodhpur, Ahmedabad-380 015, GUJARAT, INDIA.

Expires on or after
January, 2027

liver
Glimison-M 2 Tablet PR should be used carefully by individuals with liver disease. Adjusting the dose of Glimison-M 2 Tablet PR may be necessary, so it's vital to seek advice from your healthcare provider. Typically, Glimison-M 2 Tablet PR is initiated at a low dosage for those with mild to moderate liver issues. However, it is advised to avoid using this medication in individuals with severe liver disease. If you have liver concerns, consult your doctor before using Glimison-M 2 Tablet PR.

kidney
Caution should be exercised with Glimison-M 2 Tablet PR in patients with kidney disease. Dose adjustment may be necessary, and it is advised to consult your doctor. Avoid use in severe kidney disease. Regular kidney function tests are recommended during treatment.

alcohol
It is not safe to drink alcohol while taking Glimison-M 2 Tablet PR.

driving
When taking Glimison-M 2 Tablet PR, avoid driving if you experience low or high blood sugar symptoms that can affect your ability to drive safely.

pregnancy
Glimison-M 2 Tablet PR may not be safe during pregnancy. Animal studies indicate potential harm to the developing baby. Consult your doctor, as they will assess the risks and benefits before prescribing this medication to you.

breastfeeding
Glimison-M 2 Tablet PR should be avoided during breastfeeding due to potential harm to the baby.
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹62.55
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024